MOCH KENNETH I
Insider CIK 1070009 · CMRX President and CEO, Director · GMDA Director · ZYNE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GMDA Gamida Cell Ltd. | A Award | 2024-01-31 | 2024-02-02 | 200,000 | — | $0 | 232,300 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award deriv | 2023-10-19 | 2023-10-20 | 56,600 | — | $0 | 56,600 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award | 2023-10-19 | 2023-10-20 | 28,300 | — | $0 | 32,300 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 34,663 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | D To issuer deriv | 2023-10-10 | 2023-10-11 | 71,736 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 47,824 | — | $0 | 0 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | U Tender | 2023-10-10 | 2023-10-11 | 27,954 | — | $0 | 47,824 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2023-06-14 | 2023-06-15 | 115 | $0.35 | $40 | 75,778 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2023-06-13 | 2023-06-15 | 71,736 | — | $0 | 71,736 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2023-06-13 | 2023-06-15 | 47,824 | — | $0 | 75,893 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award deriv | 2023-02-08 | 2023-02-10 | 56,600 | — | $0 | 56,600 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award | 2023-02-08 | 2023-02-10 | 28,300 | — | $0 | 32,300 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award deriv | 2022-11-18 | 2022-11-22 | 9,500 | — | $0 | 9,500 | SEC↗ |
| GMDA Gamida Cell Ltd. | A Award | 2022-11-18 | 2022-11-22 | 2,000 | — | $0 | 4,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2022-06-14 | 2022-06-16 | 34,663 | — | $0 | 34,663 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2022-06-14 | 2022-06-16 | 23,109 | — | $0 | 28,109 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | S Sale | 2022-06-14 | 2022-06-16 | 40 | $1.01 | $40 | 28,069 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2021-08-03 | 2021-08-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award | 2021-08-03 | 2021-08-05 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2020-06-10 | 2020-06-11 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-10-01 | 2019-10-02 | 1,343 | $4.51 | $6.1K | 1,343 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-07-01 | 2019-07-03 | 666 | $9.10 | $6.1K | 666 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-06-11 | 2019-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-04-01 | 2019-04-03 | 1,728 | $3.51 | $6.1K | 1,728 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2019-01-02 | 2019-01-04 | 2,450 | $2.42 | $5.9K | 2,450 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-10-01 | 2018-10-02 | 1,152 | $5.16 | $5.9K | 1,152 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-07-02 | 2018-07-03 | 952 | $6.24 | $5.9K | 952 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-06-06 | 2018-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-04-02 | 2018-04-03 | 1,161 | $5.11 | $5.9K | 1,161 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2018-01-02 | 2018-01-04 | 716 | $8.29 | $5.9K | 716 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2017-10-02 | 2017-10-03 | 971 | $5.47 | $5.3K | 971 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2017-07-03 | 2017-07-06 | 500 | $10.63 | $5.3K | 500 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2017-06-07 | 2017-06-09 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2017-04-03 | 2017-04-04 | 416 | $12.77 | $5.3K | 416 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2016-05-25 | 2016-07-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ZYNE Zynerba Pharmaceuticals, I | A Award deriv | 2015-08-04 | 2015-08-06 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CMRX CHIMERIX INC | M Exercise deriv | 2014-03-13 | 2014-03-17 | 15,000 | — | $0 | 200,352 | SEC↗ |
| CMRX CHIMERIX INC | M Exercise | 2014-03-13 | 2014-03-17 | 15,000 | $1.57 | $23.6K | 20,292 | SEC↗ |
| CMRX CHIMERIX INC | S Sale | 2014-03-13 | 2014-03-17 | 18,979 | $25.00 | $474.5K | 1,313 | SEC↗ |
| CMRX CHIMERIX INC | M Exercise deriv | 2014-02-24 | 2014-02-26 | 9,072 | — | $0 | 215,352 | SEC↗ |
| CMRX CHIMERIX INC | M Exercise | 2014-02-24 | 2014-02-26 | 9,072 | $1.57 | $14.2K | 15,051 | SEC↗ |
| CMRX CHIMERIX INC | S Sale | 2014-02-24 | 2014-02-26 | 11,072 | $20.00 | $221.4K | 3,979 | SEC↗ |
| CMRX CHIMERIX INC | M Exercise deriv | 2014-01-30 | 2014-02-03 | 928 | — | $0 | 224,424 | SEC↗ |
| CMRX CHIMERIX INC | M Exercise | 2014-01-30 | 2014-02-03 | 928 | $1.57 | $1.5K | 6,907 | SEC↗ |
| CMRX CHIMERIX INC | S Sale | 2014-01-30 | 2014-02-03 | 928 | $20.00 | $18.6K | 5,979 | SEC↗ |
| CMRX CHIMERIX INC | A Award deriv | 2014-01-28 | 2014-01-30 | 190,800 | — | $0 | 190,800 | SEC↗ |
| CMRX CHIMERIX INC | M Exercise deriv | 2013-11-15 | 2013-11-19 | 8,479 | — | $0 | 0 | SEC↗ |
| CMRX CHIMERIX INC | S Sale | 2013-11-15 | 2013-11-19 | 2,500 | $15.62 | $39.0K | 5,979 | SEC↗ |
| CMRX CHIMERIX INC | M Exercise | 2013-11-15 | 2013-11-19 | 8,479 | — | $0 | 8,479 | SEC↗ |